Hydreight Technologies Appoints Dr. Roebuck As a Director of the Company

VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) ("Hydreight" or the "Company"), a North American, fully integrated, mobile clinical network of nurses, doctors, and pharmacy distribution, is pleased to announce the appointment of Dr. Jeremy Roebuck as a director of the Company, effective May 5, 2025 to fill the vacancy created by the resignation of Alexandros Tzilios as a director of the Company. The Company thanks Mr. Tzilios for his contribution and wishes him well in his future endeavors. Dr. Roebuck previously served on Hydreight's Board of Advisors since December 12, 2022.